We are live on
!
Find out more
LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$2.63B
1-Year Est. Return
31.52%
This Fund
S&P 500
This Quarter
Est. Return
-13.16%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.18B
AUM Growth
-$93.5M
(-7.3%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
9.6%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
341
New
184
Increased
50
Reduced
82
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$12.6M |
| 2 |
Manulife Financial
MFC
|
+$7.56M |
| 3 |
Glaukos
GKOS
|
+$7.01M |
| 4 |
Amazon
AMZN
|
+$6.67M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$6.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$11.7M |
| 2 |
UnitedHealth
UNH
|
+$11.3M |
| 3 |
iRhythm Holdings
IRTC
|
+$9.63M |
| 4 |
Halozyme
HALO
|
+$8.33M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$7.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.65% |
| 2 | Financials | 13.97% |
| 3 | Consumer Discretionary | 13.94% |
| 4 | Technology | 8.36% |
| 5 | Industrials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Toronto Dominion Bank
TD
$204B
| $986K | 0.08% |
15,167
-374
| -2% | -$27.2K |
|
152
Automatic Data Processing
ADP
$107B
| $982K | 0.08% |
+4,676
| New | +$1.02M |
|
153
Generac Holdings
GNRC
$13.1B
| $977K | 0.08% |
+4,641
| New | +$1.14M |
|
154
Malibu Boats
MBUU
$576M
| $975K | 0.08% |
18,500
+3,100
| +20% | +$168K |
|
155
Honeywell
HON
$74.6B
| $964K | 0.08% |
+5,885
| New | +$1.06M |
|
156
Mondelez International
MDLZ
$79.4B
| $962K | 0.08% |
15,498
+4,934
| +47% | +$312K |
|
157
AT&T
T
$166B
| $958K | 0.08% |
45,703
-16,557
| -27% | -$330K |
|
158
Broadcom
AVGO
$1.98T
| $950K | 0.08% |
+19,560
| New | +$1.1M |
|
159
Gilead Sciences
GILD
$168B
| $916K | 0.08% |
+14,823
| New | +$918K |
|
160
Comcast
CMCSA
$90.4B
| $907K | 0.08% |
23,104
-1,452
| -6% | -$62.3K |
|
161
Booking.com
BKNG
$159B
| $902K | 0.08% |
+12,900
| New | +$1.1M |
|
162
Qualcomm
QCOM
$171B
| $902K | 0.08% |
+7,065
| New | +$959K |
|
163
Alcoa
AA
$13.5B
| $895K | 0.08% |
19,639
+5,356
| +37% | +$347K |
|
164
Sysco
SYY
$40.5B
| $864K | 0.07% |
+10,205
| New | +$855K |
|
165
Freeport-McMoran
FCX
$96.9B
| $848K | 0.07% |
28,995
+1,450
| +5% | +$58K |
|
166
Idexx Laboratories
IDXX
$45B
| $842K | 0.07% |
+2,402
| New | +$979K |
|
|
SKX
167
DELISTED
Skechers
SKX
| $840K | 0.07% |
23,600
| – | – |
|
168
Hershey
HSY
$37B
| $835K | 0.07% |
+3,879
| New | +$845K |
|
169
United Parcel Service
UPS
$88.4B
| $833K | 0.07% |
+4,566
| New | +$833K |
|
170
Biogen
BIIB
$30.9B
| $825K | 0.07% |
+4,047
| New | +$827K |
|
171
Regeneron Pharmaceuticals
REGN
$82.2B
| $797K | 0.07% |
+1,348
| New | +$876K |
|
172
IBM
IBM
$222B
| $794K | 0.07% |
+5,622
| New | +$759K |
|
173
Edwards Lifesciences
EW
$53.6B
| $781K | 0.07% |
+8,216
| New | +$851K |
|
174
Newmont
NEM
$124B
| $779K | 0.07% |
+13,047
| New | +$923K |
|
175
Pembina Pipeline
PBA
$28.4B
| $764K | 0.06% |
21,794
-916
| -4% | -$35.3K |
|
Similar funds
SI
WWM
ACM
CCM
MG
PCMI
PCIG
MAMU
Lombard Odier Asset Management (Switzerland)'s Q2 2022 Portfolio in Review
As of Q2 2022, Lombard Odier Asset Management (Switzerland) held 341 positions worth $1.18B, down 7.3% from $1.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Lombard Odier Asset Management (Switzerland) deployed $113M of net new capital in Q2 2022, opening 184 new positions and adding to 50 existing holdings. Its largest new stake was Glaukos: 147,742 shares worth $6.71M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 57% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $11.7M trimmed.
- Lombard Odier Asset Management (Switzerland)'s largest Q2 2022 buy was Glaukos: 147,742 shares worth $6.71M.
- Lombard Odier Asset Management (Switzerland) added most to DexCom in Q2 2022, an estimated $12.6M increase.
- Lombard Odier Asset Management (Switzerland)'s biggest Q2 2022 reduction was AbbVie, cutting an estimated $11.7M.
- Lombard Odier Asset Management (Switzerland) fully exited G1 Therapeutics, Inc. Common Stock in Q2 2022, selling an estimated $4.12M.
- Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 21% of its $1.18B portfolio in Q2 2022.
- Lombard Odier Asset Management (Switzerland) opened 184 new positions and closed 18 in Q2 2022.
- Lombard Odier Asset Management (Switzerland)'s portfolio value fell 7.3% quarter-over-quarter to $1.18B.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 15 Aug 2022.